Zeinab Mohseni Afshar

Zeinab Mohseni Afshar

Auto-generated profile, based on publicly available information

Zeinab Mohseni Afshar

Clinical Research Development Center Imam Reza Hospital, Kermanshah University of Medical Sciences Kermanshah Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
AGAzadeh Goodarzi
Azadeh Goodarzi
SESeyed Naser Emadi
Seyed Naser Emadi
RMRonak Miladi
Ronak Miladi
SSSafoura Shakoei
Safoura Shakoei
PHParvaneh Hatami
Parvaneh Hatami
Dermatological disorders are among the most prevalent manifestations of HIV infection/acquired immunodeficiency syndrome (AIDS). In this review, we aimed to characterize the various dermatologic presentations among HIV-infected patients with a detailed categorization of the mucocutaneous signs and symptoms, their etiopathogenic factors, and clinical management. In fact, cutaneous manifestations of HIV are quite various, ranging from AIDS-specific skin eruptions (xerosis, pruritic papular eruptions, eosinophilic folliculitis, and acne), opportunistic infections (herpes simplex, molluscum contagiosum, cutaneous leishmaniasis, bacillary angiomatosis, disseminated histoplasmosis, disseminated cryptococcosis, and zoster) to AIDS-related malignancies (Kaposi’s sarcoma, lymphoma, and nonmelanoma skin cancers) and antiretroviral therapy (ART)-associated drug eruptions. We tried to classify HIV-related cutaneous presentations which can help clinicians for a better understanding of the various specific and nonspecific features of AIDS-associated cutaneous manifestations and management of the condition.

18 April 2022 in Clinical Case Reports
Verified
Journal Article
Open access
ZAZeinab Aryanian
Zeinab Aryanian
KBKamran Balighi
Kamran Balighi
PHParvaneh Hatami
Parvaneh Hatami
NTNasim Mazloumi Tootoonchi
Nasim Mazloumi Tootoonchi
AGAzadeh Goodarzi
Azadeh Goodarzi
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
Although the presence of morphea following COVID‐19 has been rarely reported, the development of its generalized form following COVID‐19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID‐19 vaccination and another similar case following SARS‐Cov‐2 infection. Other etiologic factors were also dealt with.

3 June 2022 in Clinical Case Reports
Verified
Journal Article
Open access
FMFatemeh Mohaghegh
Fatemeh Mohaghegh
PHParvaneh Hatami
Parvaneh Hatami
ARArezoo Refaghat
Arezoo Refaghat
MMMohammadjavad Mehdizadeh
Mohammadjavad Mehdizadeh
ZAZeinab Aryanian
Zeinab Aryanian
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
Development of pemphigus foliaceus (PF) following SARS‐CoV‐2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug‐induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking any culprit drug.

10 August 2022 in Case Reports in Medicine
Verified
Journal Article
Open access
PDF file
FMFatemeh Mohaghegh
Fatemeh Mohaghegh
PHParvaneh Hatami
Parvaneh Hatami
ZAZeinab Aryanian
Zeinab Aryanian
FFFarahnaz Fatemi
Farahnaz Fatemi
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.

26 September 2022 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
ZAZeinab Aryanian
Zeinab Aryanian
AEAmirhooshang Ehsani
Amirhooshang Ehsani
ZRZahra Razavi
Zahra Razavi
SHShahin Hamzelou
Shahin Hamzelou
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
PHParvaneh Hatami
Parvaneh Hatami

5 December 2022 in Clinical Case Reports
Verified
Journal Article
Open access
FMFatemeh Mohaghegh
Fatemeh Mohaghegh
PHParvaneh Hatami
Parvaneh Hatami
ARArezoo Refaghat
Arezoo Refaghat
AMAmir Hassan Matini
Amir Hassan Matini
ZAZeinab Mohseni Afshar
Zeinab Mohseni Afshar
ZAZeinab Aryanian
Zeinab Aryanian
Sarcoidosis is an inflammatory and granulomatous disorder, developed due to dysregulation between immune response and certain environmental antigens. We hereby report an interesting case of sarcoidosis following COVID‐19 vaccination (COVIran Barekat), which presented with inflammation of previous tattoo sites as well as the development of erythema nodosum and systemic lymphadenopathy, suggested a possible link between the COVID vaccination and dysregulation of the inflammatory process and served as a reminder for clinicians to have enough vigilance before proposing a vaccine booster to these patients.